
Soren Acquisition Corp.
93
Recent developments include a key management appointment relevant to the company’s operations and broader market conditions affecting SPACs and related sectors.
- Joseph Tonnos was named Managing Director of Di Rezze Family Office and became CFO of two Nasdaq-listed SPACs, including Soren Acquisition Corp., as of October 26, 2026 [N1].
- Market conditions have shown volatility due to trade uncertainty and AI-related disruption fears, impacting broader equity markets [N2].
- Billionaire activist investors have recently increased activity in certain stocks, reflecting heightened market engagement [N3].
- Several companies reported quarterly earnings results around February 2026, indicating varied sector performance but not directly related to Soren Acquisition Corp. [N4][N5][N6][N7][N8].
Soren Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) incorporated in September 2025 in the Cayman Islands. Its business model is to identify and complete a Business Combination with one or more target companies, primarily focusing on healthcare but open to other industries and geographies. The company completed its IPO in January 2026, raising gross proceeds of $253 million plus $5 million from private placement warrants, which are held in a trust account. The Management Team brings prior SPAC experience and broad sector knowledge. The company has not yet generated operating revenues and must complete its Business Combination by January 8, 2028, unless extended. The company’s financial position as of September 30, 2026, shows strong liquidity and a net income of approximately $2.19 million.
Soren Acquisition Corp. is a Cayman Islands exempted blank check company formed in September 2025 to complete a Business Combination with one or more businesses. The company completed its IPO in January 2026, raising $253 million plus $5 million from private placement warrants, with proceeds held in a trust account. The Management Team has prior SPAC experience and intends to focus on healthcare but may consider other sectors. As of September 30, 2026, the company reported net income of $2.19 million and strong liquidity with a current ratio of 22.01. No operating revenues have been generated to date. Recent news includes the appointment of Joseph Tonnos as CFO. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.
The company’s experienced Management Team with a track record of successful SPAC combinations may attract attractive target businesses, particularly in healthcare. The strong liquidity position and substantial IPO proceeds provide financial flexibility to pursue sizable acquisitions. The ability to leverage operational and strategic expertise post-Business Combination could enhance value creation for shareholders.
The company has not yet identified a Business Combination target and faces the risk of failing to complete a combination by the deadline, which would result in liquidation. Dilution risks exist due to Founder Shares, Private Placement Warrants, and potential equity issuances. The company’s success depends heavily on the Management Team’s ability to identify and execute a suitable Business Combination. Market conditions and shareholder redemptions could also impact the ability to close a transaction.
As a SPAC, Soren Acquisition Corp.'s moat is primarily derived from the experience and capabilities of its Management Team, which has successfully completed multiple prior SPAC Business Combinations. The team's broad sector knowledge and capital markets experience provide access to potential target businesses and capital sources. However, the company has not yet completed a Business Combination and thus has no operating business or competitive advantages beyond its management expertise and capital structure.
• Business Combination Risk: Failure to identify or complete a Business Combination by January 8, 2028, or any approved extension, would result in liquidation and return of funds to shareholders.
• Dilution Risk: Public Shareholders may experience dilution from Founder Shares, Private Placement Warrants, and any additional equity or convertible debt issuances.
• Management and Sponsor Risk: The Sponsor or key personnel may divest their interests before a Business Combination, potentially resulting in loss of key management and impacting the company’s ability to complete a transaction.
• Market and Redemption Risk: Shareholder redemptions in connection with a Business Combination could reduce available capital and complicate closing conditions.
Business trends: Continued focus on identifying and completing a Business Combination with potential targets primarily in healthcare but open to other sectors.
Execution milestones: Completion of the initial Business Combination by January 8, 2028, or any approved extension; management appointments and capital deployment.
Key risks: Failure to complete a Business Combination within the deadline, dilution from warrants and founder shares, potential loss of key management, and shareholder redemptions impacting capital availability.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Soren Acquisition Corp. is a blank check company incorporated on September 2, 2025, as a Cayman Islands exempted company formed to effect a Business Combination with one or more businesses or entities.
- As of the latest 10-K filing dated March 27, 2026, the company has not selected any Business Combination target and has generated no operating revenues to date.
- The company completed its Initial Public Offering (IPO) on January 8, 2026, selling 25,300,000 Units at $10.00 per Unit, generating gross proceeds of $253 million.
- Each Unit consists of one Public Share and one-third of one Public Warrant, with each whole Public Warrant exercisable to purchase one Class A Ordinary Share at $11.50 per share.
- Simultaneously with the IPO, the company completed a private sale of 5,000,000 Private Placement Warrants to its Sponsor, generating $5 million in gross proceeds.
- The proceeds from the IPO and Private Placement were placed in a Trust Account maintained by Continental as trustee.
- The company’s Management Team is led by CEO Arghavan Di Rezze and CFO Jamie Weber, supported by Advisors Peter Ondishin and Nicholas Shekerdemian.
- The Management Team has prior experience successfully identifying and closing four SPAC Business Combinations across various industries and capital markets.
- The company intends to focus on target businesses primarily in the healthcare industry but may pursue opportunities in any business, industry, sector, or geographical location.
- The company seeks to acquire established businesses of scale with growth potential and capable management teams, potentially needing financial, operational, strategic, or managerial enhancements.
- The company must complete its initial Business Combination by January 8, 2028, unless it pursues an extension approved by shareholders.
- The company’s Sponsor holds Founder Shares and Private Placement Warrants that may cause dilution to Public Shareholders upon conversion or exercise.
- The company’s financial snapshot as of September 30, 2026, shows current assets of $1,843,472 and current liabilities of $83,752, resulting in a current ratio of 22.01, indicating strong liquidity.
- The company reported net income of $2,188,508 for the period ending September 30, 2026, and basic and diluted EPS of -$0.01 for the fiscal year ending December 31, 2025.
- There have been no material changes to the risk factors disclosed in the Annual Report filed on March 27, 2026.
- Joseph Tonnos was named Managing Director of Di Rezze Family Office and became CFO of two Nasdaq-listed SPACs, including Soren Acquisition Corp., as of October 26, 2026.
Generated 2026-11-13
- S1 | 2026-03-27 | 10-K
- S2 | 2026-11-13 | 10-Q
- N1 | 2026-10-26 | www.nasdaq.com | Di Rezze Family Office Names Joseph Tonnos Managing Director; Tonnos Becomes CFO of Two Nasdaq-Listed SPACs | https://www.nasdaq.com/press-release/di-rezze-family-office-names-joseph-tonnos-managing-director-tonnos-becomes-cfo-two-1
- N2 | 2026-02-24 | www.nasdaq.com | Stocks Finish Sharply Lower on Trade Uncertainty and AI-Disruption Fears | https://www.nasdaq.com/articles/stocks-finish-sharply-lower-trade-uncertainty-and-ai-disruption-fears
- N3 | 2026-02-24 | www.nasdaq.com | Billionaire Activist Investors Just Started to Rattle the Cages of These Two Stocks. Is It Time to Buy? | https://www.nasdaq.com/articles/billionaire-activist-investors-just-started-rattle-cages-these-two-stocks-it-time-buy
- N4 | 2026-02-24 | www.nasdaq.com | Primoris Services (PRIM) Tops Q4 Earnings and Revenue Estimates | https://www.nasdaq.com/articles/primoris-services-prim-tops-q4-earnings-and-revenue-estimates
- N5 | 2026-02-24 | www.nasdaq.com | Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates | https://www.nasdaq.com/articles/vir-biotechnology-inc-vir-reports-q4-loss-beats-revenue-estimates
- N6 | 2026-02-24 | www.nasdaq.com | Douglas Dynamics (PLOW) Surpasses Q4 Earnings and Revenue Estimates | https://www.nasdaq.com/articles/douglas-dynamics-plow-surpasses-q4-earnings-and-revenue-estimates
- N7 | 2026-02-24 | www.nasdaq.com | Helix Energy (HLX) Q4 Earnings and Revenues Top Estimates | https://www.nasdaq.com/articles/helix-energy-hlx-q4-earnings-and-revenues-top-estimates
- N8 | 2026-02-24 | www.nasdaq.com | Brighthouse Financial (BHF) Q4 Earnings and Revenues Miss Estimates | https://www.nasdaq.com/articles/brighthouse-financial-bhf-q4-earnings-and-revenues-miss-estimates
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


